Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26076126 | 1.00 | ALDH1A1 (0.56) | ALDH1A1PTGS1MAPTTSHRSLC7A5 | |
| SCHEMBL498110 | 1.00 | ALDH1A1 (0.56) | ALDH1A1PTGS1MAPTTSHRSLC7A5 | |
| SCHEMBL2783864 | 0.81 | MAPT (0.54) | ALDH1A1PTGS1MAPTTSHRSLC7A5 | |
| SCHEMBL27476927 | 0.81 | ALDH1A1 (0.42) | ALDH1A1PTGS1MAPTTSHRSLC7A5 | |
| SCHEMBL30621982 | 0.81 | ALDH1A1 (0.54) | ALDH1A1PTGS1MAPTTSHRSLC7A5 | |
| Glutamic Acid SCHEMBL28540437 | 0.80 | GRM8 (0.64) | MAPTGRIK1SLC1A3SLC1A2SLC1A1 | |
| D-Glutamate SCHEMBL28540438 | 0.80 | GRM8 (0.64) | MAPTGRIK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL14689821 | 0.79 | ALDH1A1 (0.38) | ALDH1A1PTGS1MAPTSLC7A5ENPEP | |
| SCHEMBL5296691 | 0.77 | ALDH1A1 (0.50) | ALDH1A1PTGS1MAPTSLC7A5ENPEP | |
| SCHEMBL6433 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | claimed |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2024-08-29 | — | — | US | claimed |
| EP-4295866-A2 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2023-12-27 | — | — | EP | claimed |
| EP-3638284-B1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2023-08-30 | — | — | EP | claimed |
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2023-06-20 | — | — | US | claimed |
| US-20210101941-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2021-04-08 | — | — | US | claimed |
| EP-3638284-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2020-04-22 | — | — | EP | claimed |
| WO-2018229156-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2018-12-20 | — | — | WO | claimed |
| EP-3335720-A1 | C-DI-GMP BINDING PEPTIDES | Universität Basel (CH) | 2018-06-20 | — | — | EP | claimed |
| CN-106882972-A | The recoverying and utilizing method of AZS grinding waste material | 宋林祥 | 2017-06-23 | — | — | CN | claimed |
| CN-106810282-A | The method for producing ramming mass using the useless brick of AZS | 宋林祥 | 2017-06-09 | — | — | CN | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-20260137767-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VIROMETIX AG (CH) | 2026-05-21 | — | — | US | disclosed |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | disclosed |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2026-01-29 | — | — | US | disclosed |
| US-12465633-B2 | Lipopeptide building blocks and synthetic virus-like particles | VIROMETIX AG (CH) | 2025-11-11 | — | — | US | disclosed |
| US-4696981-A | ANHYDROPOLYASPARTIC ACID (IMIDE) FROM AMMONIUM SALT OR AMIDE OF MALIC OR MALEIC ACID | DIAMOND SHAMROCK CHEMICALS COMPANY (US) | 1987-09-29 | — | — | US | disclosed |
| US-4590260-A | SUITABLE FOR INDUSTRIAL USE | FUSO CHEMICAL CO., LTD. (JP) | 1986-05-20 | — | — | US | disclosed |
| EP-0178903-A2 | Improved tellurium imaging composition and film including imide or ammonium salt | ENERGY CONVERSION DEVICES, INC. (US) | 1986-04-23 | — | — | EP | disclosed |
| US-3957760-A | AMINO ACID DERIVATIVES | E. R. SQUIBB & SONS, INC. (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIP, LNPEP, CSTB | ALDH1A1 4763/4885PTGS1 3221/4885MAPT 4608/4885 |
| US-20260137767-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VSIR, LRBA, CD74 | ALDH1A1 4871/4885PTGS1 2706/4885MAPT 2698/4885 |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | PHAX, TPX2, MLX | ALDH1A1 4340/4885PTGS1 3112/4885MAPT 4773/4885 |
| US-12465633-B2 | Lipopeptide building blocks and synthetic virus-like particles | VSIR, CXCL10, SGTA | ALDH1A1 4850/4885PTGS1 4511/4885MAPT 2019/4885 |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIP, QPCT, QPCTL | ALDH1A1 4864/4885PTGS1 4400/4885MAPT 4709/4885 |
| US-20210101941-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | QPCT, QPCTL, VIP | ALDH1A1 4852/4885PTGS1 4222/4885MAPT 4685/4885 |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | CTH, VIP, CXCL10 | ALDH1A1 4815/4885PTGS1 3432/4885MAPT 4663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.